UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Medison Pharma’s Amvuttra reimbursement could reshape hATTR-PN treatment in Korea

Source
koreabiomed

Medison Pharma’s Amvuttra (vutrisiran) has entered Korea’s reimbursement system for hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN), raising expectations that the RNA interference-based therapy could improve treatment access and encourage earlier diagnosis of a rare but rapidly progressive disease.

The company held a press conference in Seoul on Wednesday to mark the local reimbursement of Amvuttra for hATTR-PN.

출처 : KBR(https://www.koreabiomed.com)